Arrivent Biopharma Inc (AVBP)

Operating Expenses

$52.69M

Quarterly · Period ending: · USD

AVBP logo

AVBP Operating Expenses

Latest reported$52.69M
AVBP Quarterly Operating Expenses ($7.35M → $52.69M)
High-resolution chart · PNG

AVBP operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
52,691,000
46,111,000
38,823,000
38,316,000
33,623,000
66,772,000
23,705,000
24,232,000
25,697,000
20,674,000
23,118,000
16,716,000
22,584,000
12,172,000
10,442,000
11,768,000
7,348,000
7,348,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.